Brief: Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results And Operational Updates
06/11/2023 12:21
Nov 6 (Reuters) - Zentalis Pharmaceuticals Inc ZNTL.O :
* ZENTALIS PHARMACEUTICALS REPORTS THIRD QUARTER 2023
FINANCIAL
RESULTS AND OPERATIONAL UPDATES
* ZENTALIS PHARMACEUTICALS INC - $517 MILLION CASH BALANCE
AS OF
SEPTEMBER 30, 2023, WITH PROJECTED CASH RUNWAY INTO 2026
* ZENTALIS PHARMACEUTICALS INC - AZENOSERTIB PROGRAMS ON
TRACK FOR
FIRST NDA SUBMISSION IN A GYNECOLOGIC MALIGNANCY IN 2026
Source text for Eikon: ID:nGNXvD06R
Further company coverage: ZNTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer